Stock Selection: Muse Spark 1.1's picks for 2026-10-28
Muse Spark 1.1 picked MSFT, GOOGL, VRT, AXGN, HRI for a 1-day horizon. Portfolio return vs SPY: +0.84%. Picks that beat SPY: 60%.
| Experiment | Stock Selection |
|---|---|
| Model | Muse Spark 1.1 |
| Prompt version | stock-selection-v8 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-28 |
| Measured to | 2026-10-29 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | +0.84% |
| Picks that beat SPY | 60% |
| Benchmark return | -0.25% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | MSFT | -0.63% | 74% | -0.39% | No |
| 2 | GOOGL | -12.08% | 70% | -11.83% | No |
| 3 | VRT | +6.02% | 72% | +6.27% | Yes |
| 4 | AXGN | +5.67% | 68% | +5.92% | Yes |
| 5 | HRI | +4.00% | 65% | +4.25% | Yes |
The model's market view
SPY trading ~771.6 up 0.25% intraday Oct 28 with narrow 0.3% range ahead of FOMC decision at 2pm ET expected 94-95% hold. Major catalysts are MSFT and GOOGL reporting after close Oct 28 and Fed guidance. Tech led early gains Oct 28 while market awaits earnings. If Fed holds dovish, growth and AI infrastructure should outperform SPY over next session; earnings beats today already driving momentum in VRT, AXGN, HRI.
Why each pick
MSFT
Thesis: Reports Q1 FY27 after close Oct 28. 【entity-Azure¦canonical_name=Azure】 growth and AI deals are key drivers; stock recently pushed above $4T market cap with intraday high near $553 and 【entity-Scotiabank¦canonical_name=Scotiabank】 raised target to $625 citing sector outperform. Up 1.5% Oct 26 on upgrade. Fed hold 94% favors long-duration tech. Positioned for beat and positive guidance to drive Oct 29 open outperformance vs SPY. Price is delayed intraday quote Oct 28 from finnhub. Risks: High expectations priced, any miss on 【entity-Azure¦canonical_name=Azure】 or margin could cause sharp reversal; hawkish Fed surprise with 10Y near 4.995% would pressure valuation; correlation with SPY 0.69 limits relative alpha if broad market sells off.
GOOGL
Thesis: Also reports after close Oct 28 with GOOG. Down 5.61% 1-month, trading 20.8% below May high 408.61, P/E 15.93 attractive vs peers, beta 1.21. Cloud and search resilience expected; oversold setup gives more upside into earnings. Options market pricing move. If beats, likely to outperform SPY on Oct 29 morning session included in window to 12:25 ET. Price is delayed intraday quote Oct 28 from finnhub. Risks: Regulatory and AI search disruption concerns; miss on ad revenue or Cloud could cause underperformance; Fed decision volatility could lift SPY more defensively.
VRT
Thesis: Reported Q3 Oct 28 before open: EPS $2.21 vs $1.82 consensus beat by $0.39, revenue $4.313B up 61% YoY beating estimates, raised 2026 guidance by $650M, organic orders more than doubled. AI data center power and cooling demand directly benefits. Stock up 13.94% intraday to 237.63, second major post-earnings melt-up in 2026 per Schaeffers, analyst PT $329. Momentum likely to carry into next session vs flat SPY. Price is delayed intraday quote Oct 28 from finnhub. Risks: High beta 2.12 and 52-week high 379.93 leaves room for profit taking; valuation P/E 44.9; if Fed signals hike risk for December 75% odds, capex cyclicals could fade.
AXGN
Thesis: Reported Q3 Oct 28 before open, beat and raised 2026 revenue guidance. Breast segment revenue surged over 50% YoY driving accelerated growth. Stock up 28.07% intraday to 47.975 with 5-day return 36.14% and 1-year 165%. Small-cap biotech guidance raises often see follow-through next day as coverage revises. Low float and high short interest can amplify outperformance vs SPY. Price is delayed intraday quote Oct 28 from finnhub. Risks: Small cap $2.23B, high volatility, already extended 9.2% above trading range; any reversal in biotech sentiment or broader risk-off after Fed could underperform SPY.
HRI
Thesis: Reported Q3 Oct 27 before open: EPS $3.91 vs $2.92 consensus, surprise +26.95%, revenue $1.36B up 4.6% YoY above $1.35B estimate, raised guidance. Equipment rental levered to non-residential construction and infrastructure. Stock jumped 22.72% Oct 27 and continued +5.72% intraday Oct 28 to $164.99 showing two-day momentum into Fed decision. Benefits if Fed holds steady at 4% as expected, supporting construction demand. Price is intraday quote Oct 28 from MarketBeat. Risks: High leverage concerns noted by Simply Wall St, cyclical exposure to rates; if Fed hints December hike 75% odds, industrials could lag; large move already may be faded.
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| Gemini 3.6 Flash High | VRT, AMD, GOOGL, TSM, MSFT | -1.21% | 40% |
| Perplexity | MU, AVGO, SMH, TSM, CRWV | +0.24% | 20% |
| Claude Sonnet 5.5 | NVDA, GOOGL, MSFT, AVGO, SMH | -2.90% | 0% |
| GPT-6 | VRT, MU, LRCX, SNDK, AVGO | +0.63% | 40% |
| DeepSeek | MU, VRT, WDC, SNDK, SMH | +0.74% | 40% |
Written up on ForecastNest Insights: Stock Selection: Muse Spark 1.1's picks for 2026-10-28.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.